Yamo Pharmaceuticals
PrivateLast Round
VC Round
Nov 10, 2021
Company Overview
Yamo Pharmaceuticals is a clinical-stage biotechnology company developing L1-79, an oral therapy designed to treat the core social-interaction symptoms of Autism Spectrum Disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yamo Pharmaceuticals Comparables
Compare Yamo Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curemark | 85% | |
| Astrogen, Inc. | 83% | |
| PaxMedica, Inc. | 82% | |
Yamo Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 10, 2021 |
Key People
Founding team and executive leadership
Yamo Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Autism Impact Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors increased 46% MoM.
- Nov 10, 2021
Autism Impact Fund led the round.
Yamo Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Yamo Pharmaceuticals's valuation, stock price, and market status.